Ashton Thomas Securities LLC Acquires New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 246 shares of the financial services provider’s stock, valued at approximately $36,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Blue Fin Capital Inc. boosted its stake in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after purchasing an additional 74 shares in the last quarter. Security National Bank of SO Dak boosted its position in iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. grew its stake in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its holdings in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC lifted its stake in shares of iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after acquiring an additional 82 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $143.80 on Thursday. The stock’s 50 day simple moving average is $144.78 and its 200 day simple moving average is $141.57. iShares Biotechnology ETF has a 1 year low of $116.70 and a 1 year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.